| Application no. and date | 20734871.5 (espacenet) (Federated) (European Patent Register), 20200619 | | Patent/reg. no. and date | DK/EP 3986897, 20230830 | | Publication date | 20220427 | | Priority no. and date | EP 19181754, 20190621 | | EP pub. no. and date |
EP 3986897 20220427 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | | Applicant ref. no. | P83344DK01 | | Inventor | KUHN, Bernd, c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel, CH,
JAESCHKE, Georg, c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel, CH,
RICCI, Antonio, c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel, CH,
RUEHER, Daniel, c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel, CH,
DOLENTE, Cosimo, c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel, CH,
OBST SANDER, Ulrike, c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel, CH,
STEINER, Sandra, c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel, CH,
GOERGLER, Annick, c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel, CH,
NAGEL, Yvonne, Alice, c/o F. Hoffmann-La Roche AG Grenzacherstrasse 124
4070 Basel, CH,
HEWINGS, David, c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/4439 (2006.01) , A61K 31/454 (2006.01) , A61K 31/4709 (2006.01) , A61K 31/496 (2006.01) , A61K 31/5377 (2006.01) , A61P 35/00 (2006.01) , C07D 487/04 (2006.01) | | Title | EGFR-hæmmer til cancerbehandling | | Int. application no. | EP2020067076 | | Int. publication no. | WO2020254562 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
